| |
| |
|
| Insider
Information: |
Kelly Thomas Patrick |
| Relationship: |
|
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
80,350 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,037,676 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
80,350 |
|
|
| Total
Value |
$2,037,676 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
10
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.3
|
| Percentage
Gain/Loss : |
0.0%
|
 349.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Deciphera Pharmaceuticals, Inc. |
DCPH |
|
2024-02-16 |
80,350 |
2019-01-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2024-02-16 |
4 |
S |
$15.62 |
$47,009 |
D/D |
(3,010) |
80,350 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
17,275 |
83,360 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2024-01-16 |
4 |
S |
$14.47 |
$35,234 |
D/D |
(2,435) |
66,085 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2023-12-13 |
4 |
S |
$15.37 |
$42,905 |
D/D |
(2,792) |
68,520 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2023-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,244 |
71,312 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2023-10-30 |
4 |
S |
$12.02 |
$27,833 |
D/D |
(2,316) |
63,068 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2023-10-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,244 |
65,384 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2023-06-16 |
4 |
S |
$14.40 |
$23,835 |
D/D |
(1,655) |
57,140 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2023-02-16 |
4 |
S |
$15.10 |
$20,686 |
D/D |
(1,370) |
58,795 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2023-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,488 |
60,165 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2023-01-17 |
4 |
S |
$21.24 |
$51,043 |
D/D |
(2,403) |
43,677 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2022-06-16 |
4 |
S |
$10.75 |
$19,006 |
D/D |
(1,768) |
46,080 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2022-02-16 |
4 |
S |
$9.05 |
$12,380 |
D/D |
(1,368) |
47,848 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
20,500 |
49,216 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2021-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,100 |
28,716 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2021-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
11,100 |
17,616 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2021-02-16 |
4 |
S |
$48.87 |
$25,608 |
D/D |
(524) |
6,516 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2020-09-14 |
4 |
AS |
$50.01 |
$150,036 |
D/D |
(3,000) |
7,040 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2020-09-14 |
4 |
OE |
$1.89 |
$5,670 |
D/D |
3,000 |
10,040 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2020-09-10 |
4 |
OE |
$1.89 |
$5,670 |
D/D |
3,000 |
10,040 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2020-09-10 |
4 |
AS |
$47.71 |
$143,126 |
D/D |
(3,000) |
7,040 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2020-09-08 |
4 |
AS |
$44.69 |
$272,929 |
D/D |
(6,000) |
7,040 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2020-09-08 |
4 |
OE |
$1.89 |
$11,340 |
D/D |
6,000 |
13,040 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2020-05-11 |
4 |
AS |
$55.08 |
$662,240 |
D/D |
(12,000) |
7,040 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Financial Officer |
• – – |
2020-05-11 |
4 |
OE |
$1.89 |
$22,680 |
D/D |
12,000 |
19,040 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
